Exact FDA event identifier

Event 69250

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: August 13, 2014
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: VistaPharm, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. Manufactured by VistaPharm Inc., Largo, FL 33771. NDC 66689-031-01.

D-0010-2015

Recall number: D-0010-2015
Initiated: August 13, 2014
Classification: Class II
Status: Terminated
Recalling firm: VistaPharm, Inc.
Quantity: 322,650 Cups

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Defective Container: Product leaks when inverted.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: Product leaks when inverted.

Code information

Lot #: 283700, Expiry: 11/14; Lot #: 291400, Expiry: 01/15; and Lot #: 303500, Expiry: 04/15.

Distribution pattern

U.S. Nationwide, including Puerto Rico